- Home
- CNET vs XRTX Comparison
CNET vs XRTX Comparison
Compare CNET & XRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNET
- XRTX
- Stock Information
- Founded
- CNET 2003
- XRTX 2011
- Country
- CNET Hong Kong
- XRTX Canada
- Employees
- CNET N/A
- XRTX N/A
- Industry
- CNET Advertising
- XRTX Pharmaceuticals and Biotechnology
- Sector
- CNET Consumer Discretionary
- XRTX Health Care
- Exchange
- CNET Nasdaq
- XRTX Nasdaq
- Market Cap
- CNET 4.0M
- XRTX 4.2M
- IPO Year
- CNET N/A
- XRTX N/A
- Fundamental
- Price
- CNET $1.52
- XRTX $0.83
- Analyst Decision
- CNET
- XRTX
- Analyst Count
- CNET 0
- XRTX 0
- Target Price
- CNET N/A
- XRTX N/A
- AVG Volume (30 Days)
- CNET 7.9K
- XRTX 72.7K
- Earning Date
- CNET 08-14-2025
- XRTX 08-15-2025
- Dividend Yield
- CNET N/A
- XRTX N/A
- EPS Growth
- CNET N/A
- XRTX N/A
- EPS
- CNET N/A
- XRTX N/A
- Revenue
- CNET $7,688,000.00
- XRTX N/A
- Revenue This Year
- CNET N/A
- XRTX N/A
- Revenue Next Year
- CNET N/A
- XRTX N/A
- P/E Ratio
- CNET N/A
- XRTX N/A
- Revenue Growth
- CNET N/A
- XRTX N/A
- 52 Week Low
- CNET $0.96
- XRTX $0.66
- 52 Week High
- CNET $4.53
- XRTX $2.59
- Technical
- Relative Strength Index (RSI)
- CNET 54.36
- XRTX 50.81
- Support Level
- CNET $1.20
- XRTX $0.77
- Resistance Level
- CNET $1.60
- XRTX $0.84
- Average True Range (ATR)
- CNET 0.09
- XRTX 0.06
- MACD
- CNET 0.02
- XRTX 0.00
- Stochastic Oscillator
- CNET 72.58
- XRTX 67.57
About CNET ZW Data Action Technologies Inc.
ZW Data Action Technologies Inc is engaged in providing Internet advertising, precision marketing, e-commerce online to offline (O2O) advertising and marketing services as well as related data and technical services to small and medium enterprises in the PRC. It offers a variety channel of advertising and marketing services through its system, including distribution of the right to use search engine marketing services, provision of online advertising placements on its web portals, provision of e-commerce O2O advertising and marketing services, and provision of other related value-added data and technical services to maximize market exposure and effectiveness for clients.
About XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.